Pages that link to "Q34991274"
Jump to navigation
Jump to search
The following pages link to Relationship between initial vancomycin concentration-time profile and nephrotoxicity among hospitalized patients (Q34991274):
Displaying 50 items.
- Association between the AUC0-24/MIC Ratio of Vancomycin and Its Clinical Effectiveness: A Systematic Review and Meta-Analysis (Q26770913) (← links)
- European perspective and update on the management of nosocomial pneumonia due to methicillin-resistant Staphylococcus aureus after more than 10 years of experience with linezolid (Q26823518) (← links)
- Vancomycin-Associated Nephrotoxicity: The Obesity Factor (Q30278775) (← links)
- Dosing of antibacterial agents in obese adults: does one size fit all? (Q30362353) (← links)
- Novel pandemic influenza A (H1N1) and community-associated methicillin-resistant Staphylococcus aureus pneumonia. (Q30370676) (← links)
- Prevention of vancomycin induced nephrotoxicity: a review of preclinical data (Q30569251) (← links)
- Vancomycin-induced thrombocytopenia without isolation of a drug-dependent antibody (Q33403804) (← links)
- Safety profiles of old and new antimicrobials for the treatment of MRSA infections. (Q33429168) (← links)
- Clinical outcomes of linezolid and vancomycin in patients with nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus stratified by baseline renal function: a retrospective, cohort analysis (Q33716771) (← links)
- The Daniel K. Inouye College of Pharmacy Scripts: Obesity: The Drug Dose Debate (Q33763123) (← links)
- Use of vancomycin pharmacokinetic-pharmacodynamic properties in the treatment of MRSA infections (Q33881584) (← links)
- The Whole Price of Vancomycin: Toxicities, Troughs, and Time (Q33885191) (← links)
- Standard operating procedures for antibiotic therapy and the occurrence of acute kidney injury: a prospective, clinical, non-interventional, observational study (Q33892706) (← links)
- Vancomycin dosing: assessment of time to therapeutic concentration and predictive accuracy of pharmacokinetic modeling software. (Q33926436) (← links)
- Incidence and predisposing factors of vancomycin-induced nephrotoxicity in children (Q33939018) (← links)
- Comparative Incidence of Nephrotoxicity by Age Group among Adult Patients Receiving Vancomycin (Q33939091) (← links)
- Accidental and iatrogenic causes of acute kidney injury (Q33954859) (← links)
- Outcomes with daptomycin in the treatment of Staphylococcus aureus infections with a range of vancomycin MICs (Q33997671) (← links)
- The impact of vancomycin susceptibility on treatment outcomes among patients with methicillin resistant Staphylococcus aureus bacteremia. (Q34091829) (← links)
- Predictors and outcome of acute kidney injury in patients with acute myelogenous leukemia or high-risk myelodysplastic syndrome (Q34273833) (← links)
- Capturing the Essence of Organic Synthesis: From Bioactive Natural Products to Designed Molecules in Today’s Medicine (Q34361292) (← links)
- Empiric weight-based vancomycin in intensive care unit patients with methicillin-resistant Staphylococcus aureus bacteremia. (Q34396004) (← links)
- Impact of empiric weight-based vancomycin dosing on nephrotoxicity and mortality in geriatric patients with methicillin-resistant Staphylococcus aureus bacteraemia. (Q34415830) (← links)
- Empiric guideline-recommended weight-based vancomycin dosing and nephrotoxicity rates in patients with methicillin-resistant Staphylococcus aureus bacteremia: a retrospective cohort study (Q34583169) (← links)
- Pharmacokinetics and pharmacodynamics of intravenous daptomycin during continuous ambulatory peritoneal dialysis. (Q34926950) (← links)
- Biodegradable vancomycin-eluting poly[(d,l)-lactide-co-glycolide] nanofibres for the treatment of postoperative central nervous system infection. (Q34981072) (← links)
- Prediction of vancomycin pharmacodynamics in children with invasive methicillin-resistant Staphylococcus aureus infections: a Monte Carlo simulation (Q34989352) (← links)
- Biopsy-Proven Acute Tubular Necrosis due to Vancomycin Toxicity. (Q35055669) (← links)
- High versus low vancomycin serum trough regimen for Gram-positive infections: a meta-analysis (Q35123536) (← links)
- Effect of vancomycin serum trough levels on outcomes in patients with nosocomial pneumonia due to Staphylococcus aureus: a retrospective, post hoc, subgroup analysis of the Phase 3 ATTAIN studies (Q35141184) (← links)
- Prophylactic antibiotic administration for post cardiothoracic surgery sternal wounds: a retrospective study (Q35238093) (← links)
- Prediction of Failure in Vancomycin-Treated Methicillin-Resistant Staphylococcus aureus Bloodstream Infection: a Clinically Useful Risk Stratification Tool (Q35270746) (← links)
- Penetration of vancomycin into epithelial lining fluid in healthy volunteers (Q35598408) (← links)
- Relationship between Vancomycin Trough Concentrations and Nephrotoxicity: a Prospective Multicenter Trial (Q35598479) (← links)
- Comparison of Arbekacin and Vancomycin in Treatment of Chronic Suppurative Otitis Media by Methicillin Resistant Staphylococcus aureus (Q35649088) (← links)
- Daptomycin in the Clinical Setting: 8-Year Experience with Gram-positive Bacterial Infections from the EU-CORE(SM) Registry (Q35802607) (← links)
- Pharmacokinetic and pharmacodynamic considerations of antimicrobial drug therapy in cancer patients with kidney dysfunction (Q35819409) (← links)
- Optimization of time to initial vancomycin target trough improves clinical outcomes (Q35862844) (← links)
- Successful Utilization of High-Flux Hemodialysis for Treatment of Vancomycin Toxicity in a Child (Q35952609) (← links)
- Comparison of the pharmacokinetic properties of vancomycin, linezolid, tigecyclin, and daptomycin (Q35959546) (← links)
- Nephrotoxicity comparison of two commercially available generic vancomycin products. (Q35960929) (← links)
- The usefulness of arbekacin compared to vancomycin (Q35999171) (← links)
- Quality Assessment of U.S. Marketplace Vancomycin for Injection Products Using High-Resolution Liquid Chromatography-Mass Spectrometry and Potency Assays (Q36018817) (← links)
- Characterization of polymyxin B-induced nephrotoxicity: implications for dosing regimen design (Q36172505) (← links)
- Vancomycin and the Risk of AKI: A Systematic Review and Meta-Analysis (Q36206165) (← links)
- Pharmacodynamic Characteristics of Nephrotoxicity Associated With Vancomycin Use in Children (Q36377410) (← links)
- Usefulness of a decision tree model for the analysis of adverse drug reactions: Evaluation of a risk prediction model of vancomycin-associated nephrotoxicity constructed using a data mining procedure (Q36381339) (← links)
- Should monitoring of vancomycin be delayed? A case of likely nephrotoxicity occasioned by morbid obesity and minimal monitoring (Q36468173) (← links)
- Effects of obesity and sex on antimicrobial pharmacokinetics and acute kidney injury: validation of a preclinical model. (Q36558426) (← links)
- Pharmacodynamics of vancomycin for CoNS infection: experimental basis for optimal use of vancomycin in neonates (Q36684184) (← links)